Search results
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Abecma
Zacks via Yahoo Finance· 2 months agoBristol Myers (BMY) wins FDA approval for CAR T cell immunotherapy, Abecma, in earlier lines of...
Bristol Myers (BMY) Gets FDA Approval for Psoriasis Candidate
Zacks via Yahoo Finance· 2 years agoBristol Myers (BMY) secures an FDA nod for Sotyktu to treat adults with moderate-to-severe plaque...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 7 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
Bristol Myers (BMY) Gets FDA Nod for Data Addition to Camzyos
Zacks via Yahoo Finance· 12 months agoBristol Myers Squibb BMY announced that the FDA approved the supplemental new drug application...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 1 week agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
US FDA approves Bristol-Myers' lung cancer drug
Reuters via AOL· 7 months agoThe drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other...
Bristol Myers (BMY) Gets FDA Nod for Reblozyl Label Expansion
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) Reblozyl is now indicated in the United States as the first-line treatment of...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 1 month agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Bristol Myers Squibb Co's (NYSE: BMY) Sotyktu (deucravacitinib), an allosteric...